Equities

Shanghai United Imaging Healthcare Co Ltd

688271:SHH

Shanghai United Imaging Healthcare Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)134.50
  • Today's Change-4.19 / -3.02%
  • Shares traded4.11m
  • 1 Year change+4.09%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai United Imaging Healthcare Co Ltd is a China-based company that mainly provides medical imaging equipment, radiotherapy products, life science instruments and medical digital and intelligent solutions. Its products include Magnetic Resonance Imaging Systems (MR), X-ray Computed Tomography (CT), X-ray Imaging Systems (XR), Molecular Imaging Systems (PET/CT, PET/MR), Medical Linear Accelerator Systems (RT) and Life Science Instruments. In the field of digital diagnosis and treatment, the Company provides United Imaging Medical Cloud services to realize cloud collaboration of equipment and applications and sharing of medical resources, and to provide comprehensive solutions for end customers.

  • Revenue in CNY (TTM)10.93bn
  • Net income in CNY1.58bn
  • Incorporated2011
  • Employees7.44k
  • Location
    Shanghai United Imaging Healthcare Co LtdNo. 2258Chengbei Road, Jiading DistrictSHANGHAI 201807ChinaCHN
  • Phone+86 2 167076658
  • Fax+86 2 167076659
  • Websitehttps://www.united-imaging.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Autobio Diagnostics Co Ltd4.58bn1.27bn27.01bn5.54k21.193.21--5.902.192.197.9014.460.40791.913.93827,079.5011.3812.5914.5415.7964.9361.6227.9026.962.18--0.109346.400.045718.154.2816.7017.0311.32
APT Medical Inc1.96bn658.82m35.55bn2.16k53.9614.88--18.136.776.7720.1424.540.74751.4936.01910,130.4024.6818.1230.7121.9471.1370.3033.0227.073.05--0.005126.4935.7146.8349.1390.0944.39--
Shanghai United Img Hlthcare Co Ltd10.93bn1.58bn114.30bn7.44k72.075.95--10.461.921.9213.3323.330.43491.143.171,469,437.006.25--8.16--48.41--14.37--2.27--0.0263--23.52--19.21------
Data as of Nov 22 2024. Currency figures normalised to Shanghai United Imaging Healthcare Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

14.95%Per cent of shares held by top holders
HolderShares% Held
China Asset Management Co., Ltd.as of 30 Jun 202429.58m5.00%
E Fund Management Co., Ltd.as of 30 Sep 202425.16m4.26%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 202410.93m1.85%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 20245.17m0.87%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20245.11m0.86%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 20244.39m0.74%
GF Fund Management Co., Ltd.as of 30 Jun 20243.34m0.57%
Harvest Fund Management Co., Ltd.as of 30 Jun 20242.37m0.40%
Guotai Asset Management Co., Ltd.as of 30 Jun 20241.26m0.21%
CPIC Fund Management Co. Ltd.as of 30 Jun 20241.03m0.17%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.